Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study

Влияние синбиотиков на микробиоту кишечника в раннем возрасте: рандомизированное двойное слепое исследование
Nopaorn Phavichitr, Shugui Wang, Sirinuch Chomto, Ruangvith Tantibhaedhyangkul, Alexia Kakourou, Sukkrawan Intarakhao, S Jongpiputvanich, COLOR Study Group, Anundorn Wongteerasut, Kaouther Ben‐Amor, Rocı́o Martı́n, Steven Ting, Orapa Suteerojntrakool, Chonikarn Visuthranukul, Punnapatch Piriyanon, Guus Roeselers, Jan Knol
2021-02-11

Bifidobacterium breve M-16VClostridioides difficileinfant gut microbiotascGOS/lcFOSsynbiotic supplementation
Abstract Human milk is considered the optimal nutrition for infants and found to contain significant numbers of viable bacteria. The aim of the study was to assess the effects of a specific synbiotic combination at doses closer to the bacterial cells present in human milk, on intestinal bifidobacteria proportions (relative abundance), reduction of potential pathogens and gut physiological conditions. A clinical study was conducted in 290 healthy infants aged from 6 to 19 weeks. Infants received either a control infant formula or one of the two investigational infant formulas (control formula with 0.8 g/100 ml scGOS/lcFOS and Bifidobacterium breve M-16V at either 1 × 10 4 cfu/ml or 1 × 10 6 cfu/ml). Exclusively breastfed infants were included as a reference. Analyses were performed on intention-to-treat groups and all-subjects-treated groups. After 6 weeks of intervention, the synbiotics at two different doses significantly increased the bifidobacteria proportions in healthy infants. The synbiotic supplementation also decreased the prevalence (infants with detectable levels) and the abundance of C. difficile . Closer to the levels in the breastfed reference group, fecal pH was significantly lower while l -lactate concentrations and acetate proportions were significantly higher in the synbiotic groups. All formulas were well tolerated and all groups showed a comparable safety profile based on the number and severity of adverse events and growth. In healthy infants, supplementation of infant-type bifidobacterial strain B. breve M-16V, at a dose close to bacterial numbers found in human milk, with scGOS/lcFOS (9:1) created a gut environment closer to the breastfed reference group. This specific synbiotic mixture may also support gut microbiota resilience during early life. Clinical Trial Registration This clinical study named Color Synbiotics Study, was registered in ClinicalTrials.gov on 18 March 2013. Registration number is NCT01813175. https://clinicaltrials.gov/ct2/show/NCT01813175 .
1
All formulas were well tolerated, with comparable adverse-event profiles and growth across groups.
2
In 290 healthy infants aged 6–19 weeks, both tested doses of Bifidobacterium breve M-16V with scGOS/lcFOS significantly increased fecal bifidobacteria proportions after six weeks.
3
Synbiotic groups had lower fecal pH and higher L-lactate concentrations and acetate proportions, approaching values observed in exclusively breastfed reference infants.
4
Synbiotic supplementation reduced both the prevalence of detectable Clostridioides difficile and its abundance compared with control formula.
5
The specific synbiotic combination created an intestinal environment more similar to that of breastfed infants and may support gut microbiota resilience during early life.

Gut microbiota and intestinal physiological conditions in healthy infants during early life

Effects of scGOS/lcFOS and Bifidobacterium breve M-16V synbiotic supplementation on bifidobacteria proportions, potential pathogen levels, fecal pH, lactate and acetate, and gut microbiota resilience

Publication Details
Publication Date
2021-02-11
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Nopaorn Phavichitr
Shugui Wang
Sirinuch Chomto
Ruangvith Tantibhaedhyangkul
Alexia Kakourou
Sukkrawan Intarakhao
S Jongpiputvanich
COLOR Study Group
Anundorn Wongteerasut
Kaouther Ben‐Amor
Rocı́o Martı́n
Steven Ting
Orapa Suteerojntrakool
Chonikarn Visuthranukul
Punnapatch Piriyanon
Guus Roeselers
Jan Knol
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%